Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T19:42:27.401Z.
Calculation as of: 2026-10-06T19:42:27.401Z.
Quote observation: 2026-10-05T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
MiniMed Group, Inc.
Market Cap
$560.00M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$557.32M
Free Cash Flow Yield
N/A
TTM Avg
3.48%
3Y Avg
3.86%
5Y Avg
13.58%
Market Cap
$567.99M
Free Cash Flow Yield
44.06%
TTM Avg
19.72%
3Y Avg
17.48%
5Y Avg
17.48%
Market Cap
$576.52M
Free Cash Flow Yield
N/A
TTM Avg
7.20%
3Y Avg
7.20%
5Y Avg
7.20%
Market Cap
$539.25M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$538.80M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$583.05M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$535.91M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$585.62M
Free Cash Flow Yield
N/A
TTM Avg
2.13%
3Y Avg
14.68%
5Y Avg
12.04%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiniMed Group, Inc. (MMEDV) | $560.00M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $557.32M | N/A | 3.48% | 3.86% | 13.58% |
| CorMedix Inc. (CRMD)vs › | $567.99M | 44.06% | 19.72% | 17.48% | 17.48% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $576.52M | N/A | 7.20% | 7.20% | 7.20% |
| Monopar Therapeutics Inc. (MNPR)vs › | $539.25M | N/A | N/A | N/A | N/A |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $538.80M | N/A | N/A | N/A | N/A |
| OrthoPediatrics Corp. (KIDS)vs › | $583.05M | N/A | N/A | N/A | N/A |
| Shattuck Labs, Inc. (STTK)vs › | $535.91M | N/A | N/A | N/A | N/A |
| Fulgent Genetics, Inc. (FLGT)vs › | $585.62M | N/A | 2.13% | 14.68% | 12.04% |
| AngioDynamics, Inc. (ANGO)vs › | $590.64M | 0.09% | 0.21% | 0.21% | 0.70% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
